tradingkey.logo
搜尋

Labcorp Holdings Inc

LH
添加自選
255.620USD
-1.730-0.67%
交易中 美東報價延遲15分鐘
21.04B總市值
22.49本益比TTM

Labcorp Holdings Inc

255.620
-1.730-0.67%
查看詳細走勢圖
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-0.67%

5天

-0.59%

1月

-2.04%

6月

-3.90%

今年開始到現在

+1.89%

1年

+1.86%

TradingKey Labcorp Holdings Inc股票評分

單位: USD 更新時間: 2026-05-12

操作建議

Labcorp Holdings Inc當前公司基本面數據相對健康,最新ESG揭露屬於行業領先水平。增長潛力很大。當前估值合理,在醫療服務供應商行業排名15/75位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為308.03。中期看,股價處於平穩狀態。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Labcorp Holdings Inc評分

相關信息

行業排名
15 / 75
全市場排名
82 / 4490
所屬行業
醫療服務供應商

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
極度看空

Labcorp Holdings Inc亮點

亮點風險
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
利潤高增長
公司淨利潤處於行業前列,最新年度總收入13.95B美元
高分紅
公司屬於高分紅公司,最新股息支付率32.56%
估值低估
公司最新PE估值22.64,處於3年歷史低位
機構加倉
最新機構持股88.74M股,環比增加5.91%
CI 精選加拿大股票基金持倉
明星投資者CI 精選加拿大股票基金持倉,最新持倉734.00股

分析師目標

基於 21 分析師
買入
評級
308.032
目標均價
+21.22%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Labcorp Holdings Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Labcorp Holdings Inc簡介

Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
公司代碼LH
公司Labcorp Holdings Inc
CEOSchechter (Adam H)
網址https://www.labcorp.com/
KeyAI